Article Details

Helix BioPharma to Present NSCLC Drug Trial Plans at Q3 Summit | HBPCF Stock News

Retrieved on: 2025-09-09 16:02:49

Tags for this article:

Click the tags to see associated articles and topics

Helix BioPharma to Present NSCLC Drug Trial Plans at Q3 Summit | HBPCF Stock News. View article details on hiswai:

Excerpt

Helix BioPharma (OTC:HBPCF), a clinical-stage oncology company, will present at the Q3 2025 Investor Summit Virtual on September 16, 2025.

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo